The Governor of South Africa has suspended the administration of the dose of the vaccine against AstraZeneca’s coronavirus during the recent study which demonstrated that there is a reduction in the number of surgeries in the country.
The South African Minister of Health, Zweli Mkhize, communicated this to him, stating that a temporary suspension had been made that a committee of scientists would decide the strategy to ensure respect for its communicator, says Independent Online.
The Governor of South Africa has announced the release of one million doses of the AstraZeneca vaccine, produced by the Serum Institute of India, this month, while it is worth considering to evacuate to sanitary workers.
A study that publishes these moons and has accessed the exclusive ‘Finantial Times’ ensures that the vaccine against the AstraZeneca coronavirus is less effective against the South African variant of the virus and does not protect against live or moderate symptoms.
However, the person in charge of Salud stated that the immunization program will continue “as part of the weekly weeks, during which four weeks will be spent, we hope that Johnson & Johnson will have more Pfizer vacations” adminaran al personal sanitario.
In this sense, the authorities plan to accelerate the departure of the Johnson & Johnson evacuation, which has shown an effect against the new variant that prevails in more than 90 percent of the new contagios in the country, the Council President of South African Medical Research, Glenda Gray, and Bloomberg.
At present, South Africa has registered 1,476,135 coronavirus contagions, as well as 46,290 deaths from the pandemic, according to Johns Hopkins University.